Collective Health and Noom’s joint offering delivers cost savings, flexible cost-sharing options, and reliable access and efficient fulfillment for GLP-1 medications

Collective Health, a leader in employee health benefits, and digital healthcare leader Noom’s enterprise division, Noom Health, have partnered to deliver Collective Health + Noom Med with Smart, an enterprise weight management solution with an integrated GLP-1 drug program that is available to Collective Health employer customers.

Health Technology Insights: Study Reveals Link Between Glucose Monitor Channels and Outcomes by CCS

This partnership combines Noom’s advanced digital health management platform with Collective Health’s robust benefits administration infrastructure and personalized care navigation to deliver a seamless solution and superior member experience for weight management, including access to GLP-1 class drugs and other anti-obesity medications. The program offers cost savings, proactive member engagement, efficient medication access and lifestyle support, creating a holistic approach to weight loss and supporting long-term well-being. On average, clients covering GLP-1 drugs for weight loss would have seen potential savings of 28% by moving to the Collective Health + Noom Med with SmartRx program*. The offering addresses the increasing need for effective and affordable weight loss strategies by providing direct, cost-effective access to GLP-1 medications, bypassing traditional intermediaries and reducing overall treatment costs for Collective Health clients and their members.

Health Technology Insights: Encore Expands Robotic Instrument Remanufacturing Program

“We know that without a better cost management structure, most employers are unable to cover these life-changing medications for their population, despite their extraordinary efficacy in reducing obesity,” said Cody Fair, Chief Commercial Officer at Noom. “Our Collective Health + Noom Med with Smart program is focused on ensuring everyone has access to the care they need to meet their health goals. We view partnerships like the one with Collective Health as mission critical to ensuring affordability and accessibility of anti-obesity medications.”

Key features of Collective Health + Noom Med with Smart include:

  • Adaptive cost-sharing: Customizable member cost-sharing levels for GLP-1 medications offer predictable, manageable expenses, benefiting both employers and employees.
  • Clinically appropriate prescriptions: Noom’s clinicians provide proper GLP-1 prescriptions for those who qualify, ensuring end-to-end care.
  • Streamlined access and fulfillment: Quick and reliable pharmacy fulfillment, including home delivery of brand-name medications like Wegovy® and Zepbound®, ensuring members receive timely treatment.

With obesity affecting over 40% of U.S. adults and a global economic impact projected to surpass $4.32 trillion annually by 2035, this partnership addresses the urgent need for effective, affordable weight loss options for those who need them. By simplifying access to GLP-1 medications and reducing costs, Collective Health and Noom Health are setting a superior standard for weight management solutions.

“Collective Health’s partnership with Noom Health to offer a comprehensive enterprise weight management solution further demonstrates our commitment, and ability to strategically partner with healthcare industry leaders, to deliver well-designed, effective, and tightly integrated healthcare solutions to employers and their people,” said Manar Bustami, Vice President of Strategic Partnerships at Collective Health. “By combining Collective Health and Noom Health’s respective strengths, we are able to offer our employer customers and members an extremely powerful program to achieve sustainable weight loss and improved health outcomes, while helping our employer customers and members better manage the growing financial burden associated with GLP-1 medications for the treatment of obesity.”

Health Technology Insights: Morningside Ventures Invests in Xealth to Boost Digital Health

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – businesswire